Celldex Therapeutics (CLDX) Revenue (2010 - 2026)
Celldex Therapeutics (CLDX) recorded quarterly Revenue of $15000.0 in Q1 2026, down 87.6% quarter-over-quarter from $121000.0 in Q4 2025, and down 97.84% on a YoY basis from $695000.0 in Q1 2025.
Celldex Therapeutics (CLDX) Revenue (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Revenue history runs 17 years deep, the most recent figure standing at $15000.0 for Q1 2026.
- In Q1 2026, Revenue fell 97.84% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $866000.0 (down 88.54% YoY), while the FY2025 annual figure was $1.5 million, down 77.99% from the prior year.
- Revenue was $15000.0 for Q1 2026 at Celldex Therapeutics, down from $121000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $4.1 million in Q4 2023 to a low of $15000.0 in Q1 2026.
- Historically, Revenue has averaged $1.1 million across 5 years, with a median of $712500.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Revenue soared 832.09% in 2024, then tumbled 97.84% in 2026.
- A 5-year view of Revenue shows it stood at $1.6 million in 2022, then soared by 156.11% to $4.1 million in 2023, then tumbled by 71.56% to $1.2 million in 2024, then tumbled by 89.7% to $121000.0 in 2025, then tumbled by 87.6% to $15000.0 in 2026.
- The last three Revenue figures came in at $15000.0 (Q1 2026), $121000.0 (Q4 2025), and $730000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 967,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 407,000.00 |
| Jun 30, 2022 | 163,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 3.48 Mn |
| Mar 31, 2021 | 685,000.00 |